130 related articles for article (PubMed ID: 21795710)
1. Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate.
Zhu C; Luong R; Zhuo M; Johnson DT; McKenney JK; Cunha GR; Sun Z
J Biol Chem; 2011 Sep; 286(38):33478-88. PubMed ID: 21795710
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the p16INK4a tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate.
Lee DH; Yu EJ; Aldahl J; Yang J; He Y; Hooker E; Le V; Mi J; Olson A; Wu H; Geradts J; Xiao GQ; Gonzalgo ML; Cardiff RD; Sun Z
PLoS One; 2019; 14(1):e0211153. PubMed ID: 30677079
[TBL] [Abstract][Full Text] [Related]
3. Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells.
Lee SH; Johnson D; Luong R; Sun Z
J Biol Chem; 2015 Jan; 290(5):2759-68. PubMed ID: 25527506
[TBL] [Abstract][Full Text] [Related]
4. Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia.
Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Perez M; Muñoz-Galvan S; Cañamero M; Renner O; Carnero A
PLoS One; 2013; 8(4):e60277. PubMed ID: 23565217
[TBL] [Abstract][Full Text] [Related]
5. Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes.
Kim WK; Olson AW; Mi J; Wang J; Lee DH; Le V; Hiroto A; Aldahl J; Nenninger CH; Buckley AJ; Cardiff R; You S; Sun Z
Nat Commun; 2022 Jul; 13(1):4364. PubMed ID: 35902588
[TBL] [Abstract][Full Text] [Related]
6. Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.
Pascal LE; Su F; Wang D; Ai J; Song Q; Wang Y; O'Malley KJ; Cross B; Rigatti LH; Green A; Dhir R; Wang Z
Neoplasia; 2019 Aug; 21(8):752-764. PubMed ID: 31229879
[TBL] [Abstract][Full Text] [Related]
7. Identification of a cell of origin for human prostate cancer.
Goldstein AS; Huang J; Guo C; Garraway IP; Witte ON
Science; 2010 Jul; 329(5991):568-71. PubMed ID: 20671189
[TBL] [Abstract][Full Text] [Related]
8. Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.
Brady NJ; Bagadion AM; Singh R; Conteduca V; Van Emmenis L; Arceci E; Pakula H; Carelli R; Khani F; Bakht M; Sigouros M; Bareja R; Sboner A; Elemento O; Tagawa S; Nanus DM; Loda M; Beltran H; Robinson B; Rickman DS
Nat Commun; 2021 Jun; 12(1):3372. PubMed ID: 34099734
[TBL] [Abstract][Full Text] [Related]
9. MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.
Qiu X; Boufaied N; Hallal T; Feit A; de Polo A; Luoma AM; Alahmadi W; Larocque J; Zadra G; Xie Y; Gu S; Tang Q; Zhang Y; Syamala S; Seo JH; Bell C; O'Connor E; Liu Y; Schaeffer EM; Jeffrey Karnes R; Weinmann S; Davicioni E; Morrissey C; Cejas P; Ellis L; Loda M; Wucherpfennig KW; Pomerantz MM; Spratt DE; Corey E; Freedman ML; Shirley Liu X; Brown M; Long HW; Labbé DP
Nat Commun; 2022 May; 13(1):2559. PubMed ID: 35562350
[TBL] [Abstract][Full Text] [Related]
10. Early and delayed castrations confer a similar survival advantage in TRAMP mice.
Zhang ZX; Xu QQ; Huang XB; Zhu JC; Wang XF
Asian J Androl; 2009 May; 11(3):291-7. PubMed ID: 19398956
[TBL] [Abstract][Full Text] [Related]
11. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.
Pomerantz MM; Li F; Takeda DY; Lenci R; Chonkar A; Chabot M; Cejas P; Vazquez F; Cook J; Shivdasani RA; Bowden M; Lis R; Hahn WC; Kantoff PW; Brown M; Loda M; Long HW; Freedman ML
Nat Genet; 2015 Nov; 47(11):1346-51. PubMed ID: 26457646
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells.
Hu WY; Shi GB; Lam HM; Hu DP; Ho SM; Madueke IC; Kajdacsy-Balla A; Prins GS
Endocrinology; 2011 Jun; 152(6):2150-63. PubMed ID: 21427218
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment.
Cho YM; Takahashi S; Asamoto M; Suzuki S; Inaguma S; Hokaiwado N; Shirai T
Cancer Sci; 2003 Feb; 94(2):153-7. PubMed ID: 12708490
[TBL] [Abstract][Full Text] [Related]
14. Altered differentiation and proliferation of prostate epithelium in mice lacking the androgen receptor cofactor p44/WDR77.
Gao S; Wu H; Wang F; Wang Z
Endocrinology; 2010 Aug; 151(8):3941-53. PubMed ID: 20519372
[TBL] [Abstract][Full Text] [Related]
15. Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression.
Ide H; Seligson DB; Memarzadeh S; Xin L; Horvath S; Dubey P; Flick MB; Kacinski BM; Palotie A; Witte ON
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14404-9. PubMed ID: 12381783
[TBL] [Abstract][Full Text] [Related]
16. ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.
Li D; Zhan Y; Wang N; Tang F; Lee CJ; Bayshtok G; Moore AR; Wong EWP; Pachai MR; Xie Y; Sher J; Zhao JL; Khudoynazarova M; Gopalan A; Chan J; Khurana E; Shepherd P; Navone NM; Chi P; Chen Y
Sci Adv; 2023 Apr; 9(14):eadc9446. PubMed ID: 37018402
[TBL] [Abstract][Full Text] [Related]
17. Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer.
Ellis L; Ku S; Li Q; Azabdaftari G; Seliski J; Olson B; Netherby CS; Tang DG; Abrams SI; Goodrich DW; Pili R
Prostate; 2016 Sep; 76(13):1192-202. PubMed ID: 27225803
[TBL] [Abstract][Full Text] [Related]
18. Inflammation Impacts Androgen Receptor Signaling in Basal Prostate Stem Cells Through Interleukin 1 Receptor Antagonist.
Cooper PO; Yang J; Wang HH; Broman MM; Awdalkreem GD; Cresswell GM; Wang L; Goossens E; Lanman NA; Doerge RW; Zheng F; Cheng L; Crist SA; Braun RE; Jerde TJ; Ratliff TL
Res Sq; 2023 Dec; ():. PubMed ID: 38168414
[TBL] [Abstract][Full Text] [Related]
19. Detection and organ-specific ablation of neuroendocrine cells by synaptophysin locus-based BAC cassette in transgenic mice.
Cheng CY; Zhou Z; Nikitin AY
PLoS One; 2013; 8(4):e60905. PubMed ID: 23630575
[TBL] [Abstract][Full Text] [Related]
20. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis.
Xin L; Lawson DA; Witte ON
Proc Natl Acad Sci U S A; 2005 May; 102(19):6942-7. PubMed ID: 15860580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
